Tian He

Title: Innovations and Contributions of Inventor Tian He

Introduction

Tian He is a notable inventor based in Shandong, China. He has made significant contributions to the field of biotechnology, particularly in the development of oligosaccharides and inhibitors for medical applications. With a total of 2 patents, his work showcases innovative approaches to complex biochemical challenges.

Latest Patents

Tian He's latest patents include a method for preparing a fucosylated chondroitin sulfate oligosaccharide. This oligosaccharide is designed for application in the medical field, utilizing a chondroitin sulfate A salt as a raw material. The process involves enzymolysis, group protection operations, and glycosylation to synthesize the oligosaccharide compound.

Another significant patent is the truncated Evans Blue modified fibroblast activation protein inhibitor. This compound is formed by connecting truncated Evans Blue, a fibroblast activation protein inhibitor, and a nuclide chelating group. The resulting structure has been shown to significantly prolong the half-life in blood circulation, improve tumor uptake, and enhance retention time, making it suitable for nuclide therapy and imaging of tumors.

Career Highlights

Throughout his career, Tian He has worked with various companies, including Yantai Lannacheng Biotechnology Co., Ltd. and Yantai Dongcheng Biochemicals Co., Ltd. His experience in these organizations has contributed to his expertise in biotechnology and patent development.

Collaborations

Tian He has collaborated with notable professionals in his field, including Xiaoming Wu and Qingbao Yang. These partnerships have likely enhanced his research and innovation capabilities.

Conclusion

Tian He is a distinguished inventor whose work in biotechnology has led to valuable patents and advancements in medical applications. His contributions continue to impact the field positively.